n-leucyldoxorubicin has been researched along with Glioma in 1 studies
*Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berry, DJ; Cobb, SL; Falconer, RA; Gill, JH; Harburn, JJ; Jain, M; Loadman, PM; Mooney, CA | 1 |
1 other study(ies) available for n-leucyldoxorubicin and Glioma
| Article | Year |
|---|---|
Rationalized Computer-Aided Design of Matrix-Metalloprotease-Selective Prodrugs.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Computer-Aided Design; Drug Design; Glioma; Humans; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Molecular Docking Simulation; Prodrugs | 2017 |